NCT04642495View on ClinicalTrials.gov

Objective Visual Acuity Measurement Using Suppression of the Optokinetic Nystagmus (OKN).

CompletedOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

July 30, 2020

Study Completion Date

September 30, 2020

Conditions
Visual Acuity
Interventions
DIAGNOSTIC_TEST

"Visual acuity testing with SW , Landolt-C and Tumbling-E symbols"

Establish prediction intervals for acuity tests

Trial Locations (1)

4031

University Basel, University Eye Hospital Basel, Basel

All Listed Sponsors
lead

University of Basel

OTHER

NCT04642495 - Objective Visual Acuity Measurement Using Suppression of the Optokinetic Nystagmus (OKN). | Biotech Hunter | Biotech Hunter